Systemic lupus erythematosus (SLE) is characterized by autoantibody production, with anti-dsDNA antibodies (anti-dsDNA) being a key indicator for SLE diagnosis and disease monitoring. A new study ...
Adenosine deaminase 2 deficiency (DADA2) is an inborn error of immunity leading to systemic vasculitis, haematological manifestations, immune deficiency and/or autoimmunity. We report the case of a 26 ...
Full peer-reviewed results from the closely watched BEAT-LUPUS trial have now been published, confirming that systemic lupus erythematosus (SLE) patients can benefit from a one-two biologic punch. SLE ...
Assessment for anti-dsDNA antibodies provides some of the most significant challenges in autoantibody serology testing. Anti-dsDNA antibodies are an important biomarker for systemic lupus ...
The upper graphs in Panel A show representative flow-cytometric analyses of the percent of circulating anti-CD19 (CD3+ αCD19 chimeric antigen receptor [CAR]+) CAR T cells among total T cells at ...
The data could help clinicians better identify patients who are good fits for belimumab after rituximab. A new study has identified biomarkers that may help predict which patients with systemic lupus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results